|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net income for the year | |||||
| Depreciation and amortization | |||||
| Expected credit loss | |||||
| Deferred income taxes | |||||
| Unrealized losses (gains) on other investments | |||||
| Provisions and contingent liabilities | |||||
| Unrealized (gains) losses on financial instruments | |||||
| Interest accrued | |||||
| Share-based compensation | |||||
| Share of loss in associates | |||||
| Others | |||||
| Total | |||||
| Securities | |||||
| Credit card receivables | |||||
| Loans to customers | |||||
| Other receivables | |||||
| Compulsory and other deposits at central banks | |||||
| Other assets | |||||
| Deposits | |||||
| Payables to network | |||||
| Deferred income | |||||
| Other liabilities | |||||
| Interest paid | |||||
| Income tax paid | |||||
| Interest received | |||||
| Cash flows generated from (used in) operating activities | |||||
| Acquisition of property, plant and equipment | |||||
| Acquisition and development of intangible assets | |||||
| Investments in associates | |||||
| Acquisition of subsidiary, net of cash acquired | |||||
| Derivatives | |||||
| Cash flow generated from (used in) investing activities | |||||
| Proceeds from borrowings and financing | |||||
| Payments of borrowings and financing | |||||
| Lease payments | |||||
| Exercise of stock options | |||||
| Cash flows generated from (used in) financing activities | |||||
| Change in cash and cash equivalents | |||||
| Cash and cash equivalents - beginning of the year | |||||
| Foreign exchange rate changes on cash and cash equivalents | |||||
| Cash and cash equivalents - end of the year | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Non-cash transactions | |||||
| Shares issued to service providers | |||||
| Shares issued on business acquisition | |||||
Loading...